KCE Repository - Articles related to KCE publications
Add the result to your basket Refine your search
Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy / Irina Cleemput in Value in Health, 18(2015)04 ([06/01/2015])
[article] Acceptability and Perceived Benefits and Risks of Public and Patient Involvement in Health Care Policy : A Delphi Survey in Belgian Stakeholders [printed text] / Irina Cleemput , Author ; Wendy Christiaens , Author ; Laurence Kohn , Author ; Christian Léonard , Author ; François Daue, Author ; Alain Denis, Author . - 2015 . - 477-483.
Languages : English (eng)
in Value in Health > 18(2015)04 [06/01/2015] . - 477-483
Descriptors: Indexation
2012-70 ; Belgium ; Journal Article ; Patient Participation ; Peer Review ; Policy ; Public Health ; R195 ; Stakeholder involvementAbstract: BACKGROUND:
In systems with public health insurance, coverage decisions should reflect social values. Deliberation among stakeholders could achieve this goal, but rarely involves patients and citizens directly.
OBJECTIVES:
This study aimed at evaluating the acceptability, and the perceived benefits and risks, of public and patient involvement (PPI) in coverage decision making to Belgian stakeholders.
METHODS:
A two-round Delphi survey was conducted among all stakeholder groups. The survey was constructed on the basis of interviews with 10 key stakeholders and a review of the literature on participation models. Consensus was defined as 65% or more of the respondents agreeing with a statement and less than 15% disagreeing. Eighty stakeholders participated in both rounds. They were defined as the Delphi panel.
RESULTS:
Belgian stakeholders are open toward PPI in coverage decision processes. Benefits are expected to exceed risks. The preferred model for involvement is to consult citizens or patients, within the existing decision-making structures and at specific milestones in the process. Consulting citizens and patients is a higher level of involvement than merely informing them and a lower level than letting them participate actively. Consultation involves asking nonbinding advice on (parts of) the decision problem. According to the Delphi panel, the benefits of PPI could be increasing awareness among members of the general public and patients about the challenges and costs of health care, and enriched decision processes with expertise by experience from patients. Potential risks include subjectivity, insufficient resources to participate and weigh on the process, difficulties in finding effective ways to express a collective opinion, the risk of manipulation, and lobbying or power games of other stakeholders.
CONCLUSIONS:
PPI in coverage decision-making processes is acceptable to Belgian stakeholders, be it in different ways for different types of decisions. Benefits are expected to outweigh risks.Link for e-copy: http://www.dx.doi.org/10.1016/j.jval.2014.12.015 Format of e-copy: PDF [Requires Subscription) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3671 [article]Accreditation in stroke units of 6 European regions / Ömer R. Saka in Cerebrovascular Diseases, 35(2013)Suppl.3 ([05/01/2013])
[article] Accreditation in stroke units of 6 European regions : One name different realities [printed text] / Ömer R. Saka, Author ; Ying Sun, Author ; D Michiels, Author ; Vincent Thijs, Author ; Dimitri Hemelsoet, Author ; Marijke Eyssen , Author ; Dominique Paulus , Author . - 2013 . - 481.
Languages : English (eng)
in Cerebrovascular Diseases > 35(2013)Suppl.3 [05/01/2013] . - 481
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
2011-20 ; Belgium ; Cardiac Resynchronization Therapy Devices ; Emergency Treatment ; Journal Article ; Peer Review ; R181 ; StrokeAbstract: Background: ESO guidelines aim to promote standardised care of high quality in Europe but the organisation of acute care in stroke units (SU) largely differs between countries. This study aimed to scrutinize the accreditation or certification procedures of SU in 6 countries/regions: Scotland, Sweden, The Netherlands, France, Germany and the “London Stroke Services” (LSS). Methods: the information was collected with standardised questionnaires (25 pages) sent by mail to 12 experts from the 6 countries/regions. The research team analyzed the answers and clarified further issues by interviews. Results: an official mandatory accreditation procedure (organized and paid by governmental agencies) exists in Scotland, in LSS and in France. In Germany this procedure exists (private organizations) but is not mandatory. The accreditation process always implies at least site-visits and patient data review. Accreditation is renewed on a 1-, 3-, or 5-year basis. Some countries differentiate between types of SU (e.g. primary, comprehensive SU). The study further listed the criteria that SU must fulfil and the indicators measured for their accreditation (structure, process and outcome). Few of them refer to outcomes e.g. mortality, complications and recurrence. Incentives to encourage better quality differ between countries: public reporting of the results of the accreditation procedure, support to poor performers, benchmarking between hospitals, financial consequences. Conclusion: this exhaustive analysis gives an overview of the accreditation procedures in selected European countries. Care of high quality relies on a common evidence base but the quality assurance procedures, the indicators used as well as the consequences of the measurement largely differ between the countries. The question is to know if these various accreditation procedures result in differences in patients' outcomes. Link for e-copy: http://dx.doi.org/10.1159/000353129 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3779 [article]Analysis authors reply to Response by Corrado and colleagues / Hans Van Brabandt in BMJ (International), 354(2016) ([08/23/2016])
[article] Analysis authors reply to Response by Corrado and colleagues [printed text] / Hans Van Brabandt , Author ; Anja Desomer, Author ; Sophie Gerkens , Author ; Mattias Neyt , Author . - 2016 . - I4509.
Languages : English (eng)
in BMJ (International) > 354(2016) [08/23/2016] . - I4509
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Cardiovascular System ; Mass Screening ; Sports MedicineAbstract: We read with interest the comments from Corrado and colleagues on our paper related to pre-participation screening in young athletes.
The authors start their critique by suggesting that we are laypersons in the field of sports cardiology. The first author of our paper is a cardiologist with 30 years’ clinical experience. We are all active in critically appraising scientific literature and/or teaching evidence based medicine on a daily, professional basis. We may not be directly involved in sports cardiology, but the absence of conflicts of interest helps in being neutral when assessing scientific evidence.
Furthermore, our manuscript has been peer reviewed through our submission to The BMJ by three renowned sports cardiologists from the UK, the US, and Australia. And the report from which our paper was extracted had been reviewed previously by independent Belgian and Dutch experts.
More recently, two updated recommendations on pre-participation screening have been published, both from trusted sources. The UK National Screening Committee’s recommendation on screening to prevent sudden cardiac death (SCD) in 12-39 year olds, published in July 2015, is clear: “Systematic population screening programme is not recommended.”Link for e-copy: https://doi.org/10.1136/bmj.i4509 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4006 [article]Antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 to 2016 / Thomas Struyf in International Dental Journal, 69(2019)06 ([12/02/2019])
[article] Antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 to 2016 [printed text] / Thomas Struyf, Author ; Eline Vandael, Author ; Roos Leroy , Author ; Karl Mertens, Author ; Boudewijn Catry, Author . - 2019 . - 8 pp.
Languages : English (eng)
in International Dental Journal > 69(2019)06 [12/02/2019] . - 8 pp.
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Antibiotic Prophylaxis ; Dentistry ; Journal Article ; Peer ReviewAbstract: Objectives: To describe antimicrobial prescribing by Belgian dentists in ambulatory care, from 2010 until 2016.
Materials and methods: Reimbursement data from the Belgian National Institute for Health and Disability Insurance were analysed to evaluate antimicrobial prescribing (WHO ATC-codes J01/P01AB). Utilisation was expressed in defined daily doses (DDDs), and in DDDs and packages per 1000 inhabitants per day (DID and PID, respectively). Additionally, the number of DDD and packages per prescriber was calculated.
Results: In 2016, the dentistry-related prescribing rate of 'Antibacterials for systemic use' (J01) and 'Antiprotozoals' (P01AB) was 1.607 and 0.014 DID, respectively. From 2010 to 2016, the DID rate of J01 increased by 6.3%, while the PID rate declined by 6.7%. Amoxicillin and amoxicillin with an enzyme inhibitor were the most often prescribed products, followed by clindamycin, clarithromycin, doxycycline, azithromycin and metronidazole. The proportion of amoxicillin relative to amoxicillin with an enzyme inhibitor was low. The narrow-spectrum antibiotic penicillin V was almost never prescribed.
Conclusions: Antibiotics typically classified as broad- or extended-spectrum were prescribed most often by Belgian dentists during the period 2000-2016. Although the DID rate of all 'Antibacterials for systemic use' (J01) increased over the years, the number of prescriptions per dentist decreased since 2013. The high prescription level of amoxicillin with an enzyme inhibitor is particularly worrying. It indicates that there is a need for comprehensive clinical practice guidelines for Belgian dentists.Link for e-copy: https://doi.org/10.1111/idj.12512 Format of e-copy: PDF [Requires Subscription] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=4779 [article]Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? / Maria-Isabel Farfan-Portet in European Journal of Health Economics (The), 15(2014)3 ([04/01/2014])
[article] Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? [printed text] / Maria-Isabel Farfan-Portet, Author ; Sophie Gerkens , Author ; Isabelle Lepage-Nefkens , Author ; Imgard Vinck , Author ; Frank Hulstaert, Author . - 2014 . - 223-228.
Languages : English (eng)
in European Journal of Health Economics (The) > 15(2014)3 [04/01/2014] . - 223-228
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
2012-13 ; Biosimilar Pharmaceuticals ; Journal Article ; R199Link for e-copy: http://link.springer.com/article/10.1007/s10198-013-0538-4/fulltext.html Format of e-copy: PDF [Open Access] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3685 [article]Are systemic antibiotics indicated in children presenting with an odontogenic abscess in the primary dentition? / Roos Leroy in Clinical oral investigations, 25(2021)05 ([05/01/2021])
PermalinkAre thrombolytic drugs not evidence-based medications? / Hans Van Brabandt in Archives of Internal Medicine, 168(2008)2 ([01/28/2008])
PermalinkAssociation between physician density and health care consumption / Christian Léonard in Health Policy, 91(2009)2 ([07/01/2009])
PermalinkPermalinkBalancing evidence and public opinion in health technology assessments / Irina Cleemput in International Journal of Technology Assessment in Health Care, 22(2006)4 ([11/20/2006])
PermalinkBelgian guidelines for budget impact analyses / Mattias Neyt in Acta Clinica Belgica, 70(2015)03 ([06/01/2015])
PermalinkBelgian guidelines for economic evaluations / Nancy Thiry in International Journal of Technology Assessment in Health Care, 30(2014)06 ([12/01/2014])
PermalinkBelgian methodological guidelines for pharmacoeconomic evaluations / Irina Cleemput in Value in Health, 12(2009)04 ([07/01/2009])
PermalinkBudget impact analysis of orphan drugs in Belgium / Alain Denis in Journal of Medical Economics, 13(2010)02 ([05/01/2010])
PermalinkCalculating an intervention's (cost-)effectiveness for the real-world target population / Mattias Neyt in Health Policy, 106(2012)02 ([07/01/2012])
PermalinkPermalinkCancer screening: EU recommendations and current practice in Belgium / Mattias Neyt in Archives of Public Health, 66(2008)3 ([09/01/2009])
PermalinkCaution over use of catheter ablation for atrial fibrillation / Hans Van Brabandt in BMJ (International), 347(2013) ([09/01/2013])
PermalinkChallenges in physician supply planning / Sabine Stordeur in Human Resources for Health, 8(2010)28 ([12/08/2010])
PermalinkComorbidity in head and neck cancer / Sabine Stordeur in Oral Oncology, 102(2020)March ([03/01/2021])
PermalinkA comparative study of European rare disease and orphan drug markets / Alain Denis in Health Policy, 97(2010)2-3 ([10/01/2010])
PermalinkComparison of three instruments assessing the quality of economic evaluations / Sophie Gerkens in International Journal of Technology Assessment in Health Care, 24(2008)3 ([09/01/2008])
PermalinkContingent non-invasive prenatal testing / Wilfried Gyselaers in Prenatal Diagnosis, 35(2015)13 ([12/01/2015])
PermalinkCost-effectiveness analyses of drug eluting stents versus bare metal stents / Mattias Neyt in Health Policy, 91(2009)2 ([07/01/2009])
PermalinkCost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure / Mattias Neyt in BMJ open, 1(2011)02 ([10/01/2011])
PermalinkCost Effectiveness of Drug-Eluting Stents In Belgian Practice / Mattias Neyt in Pharmacoeconomics, 27(2009)4 ([04/01/2009])
PermalinkCost-effectiveness of Herceptin / Mattias Neyt in International Journal of Technology Assessment in Health Care, 21(2005)1 ([02/09/2005])
PermalinkCost-effectiveness of human papillomavirus vaccination in Belgium / Nancy Thiry in International Journal of Technology Assessment in Health Care, 25(2009)2 ([04/01/2009])
PermalinkCost Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention in a Belgian Context / Mattias Neyt in Applied Health Economics and Health Policy, 6(2008)1 ([10/01/2008])
PermalinkCost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium / Adriaan Blommaert in Vaccine, 32(2014)46 ([10/21/2014])
PermalinkCost-effectiveness of statins in the primary prevention of cardiovascular disease / Mattias Neyt in Acta Cardiologica, 64(2009)01 ([02/02/2009])
PermalinkA cost-utility analysis of transcatheter aortic valve implantation in Belgium / Mattias Neyt in BMJ open, 2(2012)03 ([05/04/2012])
PermalinkCritical assessment of Belgian reimbursement dossiers of orphan drugs / Alain Denis in Value in Health, 13(2010)7 ([11/01/2010])
PermalinkCrossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine / S. Christie in European Neurology, 49(2003)01 ([01/01/2003])
PermalinkPermalinkPermalinkDental attendance in preschool children / Roos Leroy in International journal of paediatric dentistry, 23(2013)02 ([03/01/2013])
PermalinkDépistage du cancer de la prostate par PSA / Françoise Mambourg in La Revue de la Médecine Générale, 315(2014)Septembre ([09/01/2014])
PermalinkDépistage du cancer du sein / Françoise Mambourg in La Revue de la Médecine Générale, 312(2014)Avril ([04/01/2014])
PermalinkDeveloping and measuring a set of process and outcome indicators for breast cancer / Sabine Stordeur in The Breast, 21(2012)03 ([06/01/2012])
PermalinkDeveloping the HTA core model for the online environment / Kristian Lampe in International Journal of Technology Assessment in Health Care, 30(2014)05 ([11/01/2014])
PermalinkDevelopment and validation of nursing resource weights for the Belgian Nursing Minimum Dataset in general hospitals / Walter Sermeus in International journal of nursing studies, 46(2009)02 ([02/02/2009])
PermalinkDevelopment of a national position paper for chronic care / Dominique Paulus in Health Policy, 111(2013)2 ([07/01/2013])
PermalinkDiagnosis and treatment of gonorrhoea / Vicky Jespers in Acta Clinica Belgica, (2020) Online ([06/02/2020])
PermalinkDiagnosis and treatment of syphilis / Vicky Jespers in Acta Clinica Belgica, (2020) Online ([06/02/2020])
PermalinkDo informal caregivers for elderly in the community use support measures? / Evi Willems in BMC Health Services Research, 16(2016)270 ([07/06/2016])
PermalinkDoes tiotropium lower exacerbation and hospitalization frequency in COPD patients / Ann Van den Bruel in BMC pulmonary medicine, 10(2010)50 ([09/21/2010])
PermalinkDrug substitution associated with a hospital stay in Belgium / Simoens, Steven in International Journal of Pharmacy Practice, 22(2014)02 ([04/01/2014])
PermalinkEagles testing positive for H5N1 imported illegally into Europe from Thailand / Carl Suetens in Euro surveillance, 8(2004)44 ([10/28/2004])
PermalinkEconomic evaluation of the use of point-of-care devices in patients with long term oral anticoagulation / Sophie Gerkens in Journal of thrombosis and thrombolysis, 34(2012)03 ([10/01/2012])
PermalinkEffect of hospital volume on processes of care and 5-year survival after breast cancer / France Vrijens in The Breast, 21(2012)03 ([06/01/2012])
PermalinkEffectiveness of catheter ablation of atrial fibrillation in Belgian practice / Hans Van Brabandt in European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2013)5 ([04/26/2013])
PermalinkEffects of time and socio-economic status on the determinants of oral health-related behaviours of parents of preschool children / Sigrid Van den Branden in European Journal of Oral Sciences, 120(2012)02 ([04/01/2012])
PermalinkEfficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention / AS Dela Pena in Journal of gastrointestinal surgery, 10(2006)4 ([04/01/2006])
PermalinkEfficacy of acute stroke units / Ömer R. Saka in Cerebrovascular Diseases, 35(2013)Suppl.3 ([05/01/2013])
PermalinkEndpoints for relative effectiveness assessment (REA) of pharmaceuticals / Mira Pavlovic in International Journal of Technology Assessment in Health Care, 30(2014)05 ([11/01/2014])
PermalinkErtapenem versus ceftriaxone and metronidazole as treatment for complicated intra-abdominal infections / NS Jr. Navarro in International journal of surgery, 3(2005)1 ([01/01/2005])
PermalinkEstimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence / Nele Goeyvaerts in Epidemics, 13(2015)Decembre ([12/01/2015])
PermalinkEUnetHTA tools and methods-falicitating uptake by training activities / I. Saeterdal in Value in Health, 18(2015)07 ([11/01/2015])
PermalinkEuropean drug reimbursement systems' legitimacy in International Journal of Technology Assessment in Health Care, 28(2012)04 ([10/01/2012])
PermalinkEvaluating fracture risk in acute ankle sprains / Pascale Jonckheer in European Journal of General Practice, 1751-1402 - Online ([12/22/2015])
PermalinkEvaluating the implementation fidelity of a multicomponent intervention for oral health promotion in preschool children / Sigrid Van den Branden in Prevention science, 16(2015)01 ([01/01/2015])
PermalinkEvaluating the need to reform the organisation of care for major trauma patients in Belgium: an analysis of administrative databases / Koen Van Den Heede in European Journal of Trauma and Emergency Surgery, 2008 ([02/23/2018])
PermalinkEvidence-based opvolging van de fysiologische zwangerschap / L. Schreurs in Tijdschrift voor geneeskunde, 72(2016)19 ([10/01/2016])
PermalinkEvidence based post graduate training / Annelies Damen in BMC medical education, 11(2011) ([10/06/2011])
PermalinkExamens préopératoires de routine pour la chirurgie non cardio-thoracique planifiée chez l'adulte / Nadia Benahmed in Revue Medicale de Bruxelles, ?(?)? ([12/19/2017])
PermalinkFactors associated with prevalence and severity of caries experience in preschool children / Dominique Declerck in Community Dentistry and Oral Epidemiology, 36(2008)02 ([04/01/2008])
PermalinkFunnel plots should become the standard methodology to identify centres deserving further scrutiny / France Vrijens in Journal of Hospital Infection, 74(2010)04 ([04/01/2010])
PermalinkGeographical differences in the incidence of thyroid cancer in Belgium / Julie Francart in Louvain médical., 133(2014)03 ([03/01/2014])
PermalinkGeographical variations in thyroid cancer incidence and the rate of screening tests for thyroid disease / Ann Van den Bruel in Thyroid, 22(2012) Septembre (S1) ([09/01/2012])
PermalinkHarmonizing HTA / I. Pasternack in International Journal of Technology Assessment in Health Care, 26(2010)02 ([04/01/2010])
PermalinkHealth technology assessment on catheter ablation of atrial fibrillation in Belgium / Hans Van Brabandt in European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15(2013)5 ([04/26/2013])
PermalinkHospital-acquired, laboratory-confirmed bloodstream infections / France Vrijens in Journal of Hospital Infection, 75(2010)03 ([04/01/2010])
PermalinkHospital networks: how to make them work in Belgium? Facilitators and barriers of different governance models / Kaat De Pourcq in Acta Clinica Belgica, 2008 ([01/01/2018])
PermalinkHow common are motor problems in children with a developmental disorder / Stefanie Pieters in Child : care, health and development., 38(2011)01 ([01/01/2012])
PermalinkHow to improve the continuity of pharmacotherapy at hospital admission and discharge / Veerle Foulon in Journal de Pharmacie de Belgique, 87(2010)04 ([12/01/2010])
PermalinkImpact of caries experience in the deciduous molars on the emergence of the successors / Roos Leroy in European Journal of Oral Sciences, 111(2003)02 ([04/01/2003])
PermalinkImpact of shortened length of stay for delivery on the required bed capacity in maternity services / Mélanie Lefevre in BMC Health Services Research, 19(2019)637 ([09/05/2019])
PermalinkImplementation of geriatric consultation teams (GCT) in acute hospitals in three European countries / Mieke Deschodt in Journal of the American Geriatrics Society, 63(2015) ([05/01/2015])
PermalinkImproved survival in patients with head and neck cancer treated in higher volume centres / Roos Leroy in European journal of cancer, 130(2020) ([05/01/2020])
PermalinkIncentives for market penetration of biosimilars in Belgium and in five European countries / Nathalie Swartenbroekx in Journal de Pharmacie de Belgique, 04(2014)Dec ([12/01/2014])
PermalinkInconsistent diagnosis of acute malnutrition by weight-for-height and mid-upper arm circumference / Dominique Roberfroid in Nutrition journal, 14(2015)01 ([08/25/2015])
PermalinkInterventions to reduce emergency department utilisation / Koen Van Den Heede in Health Policy, 120(2016)12 ([12/01/2016])
PermalinkIntroducing the non-invasive prenatal test for trisomy 21 in Belgium / Mattias Neyt in BMJ open, 4(2014)11 ([11/07/2014])
PermalinkIntroduction of emerging medical devices on the market: a new procedure in Belgium / Imgard Vinck in International Journal of Technology Assessment in Health Care, 23(2007)4 ([10/01/2007])
PermalinkIntroduction of high-risk medical devices / Mattias Neyt in Expert Review of Medical Devices, 14(2017)01 ([01/27/2017])
PermalinkIssues surrounding orphan disease and orphan drug policies in Europe / Alain Denis in Applied Health Economics and Health Policy, 8(2010)5 ([09/01/2010])
PermalinkKCE, a key actor in cancer care / Sabine Stordeur in Belgian journal of medical oncology, 10(2016)01 ([02/01/2016])
PermalinkPermalinkLeptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention / P. A Nguyen in Acta Cardiologica, 70(2015)06 ([12/31/2015])
PermalinkLombalgie chronique / Jeannine Gailly in La Revue de la Médecine Générale, 245(2007)septembre ([09/01/2007])
PermalinkPermalinkMarket introduction of innovative high risk medical devices / Imgard Vinck in European Journal of Health Law, 18(2011)05 ([12/01/2011])
PermalinkMeasuring appropriate use of antibiotics in pyelonephritis in Belgian hospitals / Cécile Camberlin in Computer methods and programs in biomedicine, 94(2009)2 ([05/01/2009])
PermalinkMeasuring oral health behaviour in Flemish health care workers / A. Defranc in Community Dental Health, 25(2008)02 ([06/01/2008])
PermalinkMesurer la qualité de l’organisation des pratiques / Roy Remmen in La Revue de la Médecine Générale, 260(2009)Februari ([02/01/2009])
PermalinkMethodological issues in epidemiological studies of periodontitis / Roos Leroy in BMC Oral Health, 10(2010) ([04/21/2010])
PermalinkMethodology for calculating a country's need for positron emission tomography scanners. / Irina Cleemput in International Journal of Technology Assessment in Health Care, 24(2008)1 ([03/01/2008])
PermalinkMethods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks / B. Ultsch in Pharmacoeconomics, 34(2016)03 ([03/01/2016])
PermalinkMise sur le marché européen des dispositifs médicaux innovants à haut risque : l’efficacité clinique et la sécurité sont-elles garanties ? / Sabine Stordeur in Revue d'Epidémiologie et de Santé Publique, 61(2013)02 ([04/01/2013])
Permalink